ウイルスおよび非ウイルスベクター市場　2024年

Report Overview

The global Viral and Non-viral Vector market was valued at US$ 551.85 million in 2023 and is anticipated to reach US$ 3505 million by 2030, witnessing a CAGR of 31.84% during the forecast period 2024-2030.

世界のウイルスおよび非ウイルスベクター市場は、2023年に5億5,185万米ドルと評価され、2030年までに3億5,500万米ドルに達すると予想されており、2024年から2030年の予測期間中に31.84％のCAGRが見られます。

North American market for Viral and Non-viral Vector is estimated to increase from $ 232 million in 2023 to reach $ 1423million by 2030, at a CAGR of 31% during the forecast period of 2024 through 2030.

Asia-Pacific market for Viral and Non-viral Vector is estimated to increase from $ 141 million in 2023 to reach $ 983 million by 2030, at a CAGR of 33.67% during the forecast period of 2024 through 2030.

The major global companies of Viral and Non-viral Vector include Lonza, Thermo Fisher Scientific, VectorBuilder, GenScript Biotech, Gene Chem, Revvity, etc. In 2023, the world’s top five vendors accounted for approximately 62.03 % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Viral and Non-viral Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non-viral Vector.

The Viral and Non-viral Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral and Non-viral Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral and Non-viral Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

•                 Thermo Fisher Scientific
•                 Lonza
•                 Azenta Life Sciences
•                 Revvity
•                 VectorBuilder
•                 Takara Bio
•                 GenScript Biotech
•                 Gene Chem
•                 Geno Meditech
•                 PackGene Biotech
•                 VIROVEK
•                 OriGen
•                 Vector BioLabs

Segment by Type

•                 AAV
•                 Lentiviruses
•                 Retroviruses
•                 Adenoviruses
•                 DNA Plasmids
•                 Others

Segment by Application

•                  Pharmaceutical and Biopharmaceutical Companies
•                 Academics and Research Institutes
•                 Others

By Region

North America

•                 United States
•                 Canada
•                 Mexico

Asia-Pacific

•                 China
•                 Japan
•                 South Korea
•                 Southeast Asia
•                 India
•                 Australia
•                 Rest of Asia

Europe

•                 Germany
•                 France
•                 U.K.
•                 Italy
•                 Russia
•                 Rest of Europe

South America

•                 Brazil
•                 Rest of South America

Middle East & Africa

•                 Middle East
•                 Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Viral and Non-viral Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview                1

1.1 Study Scope    1

1.2 Market Analysis by Type               1

1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2019 VS 2023 VS 2030        1

1.2.2 AAV              4

1.2.3 Lentiviruses 4

1.2.4 Retroviruses 5

1.2.5 Adenoviruses               5

1.2.6 DNA Plasmids            6

1.3 Market by Application  6

1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2019 VS 2023 VS 2030        7

1.3.2 Pharmaceutical and Biopharmaceutical Companies              9

1.3.3 Academics and Research Institutes          10

1.4 Assumptions and Limitations       11

1.5 Study Objectives            12

1.6 Years Considered           13

2 Global Growth Trends     14

2.1 Global Viral and Non-viral Vector Market Perspective (2019-2030)                 14

2.2 Global Viral and Non-viral Vector Growth Trends by Region                 15

2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2019 VS 2023 VS 2030        16

2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2019-2024)      18

2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030)      19

2.3 Viral and Non-viral Vector Market Dynamics           19

2.3.1 Viral and Non-viral Vector Industry Trends          19

2.3.2 Viral and Non-viral Vector Market Drivers            21

2.3.3 Viral and Non-viral Vector Market Challenges      22

2.3.4 Viral and Non-viral Vector Market Restraints       23

3 Competition Landscape by Key Players        24

3.1 Global Top Viral and Non-viral Vector Players by Revenue   24

3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2019-2024)      24

3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2019-2024)           25

3.2 Global Viral and Non-viral Vector Market by Company Type (Tier 1, Tier 2, and Tier 3)                26

3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue                 27

3.4 Global Viral and Non-viral Vector Market Concentration Ratio                 28

3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI)               28

3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2023   29

3.5 Global Key Players of Viral and Non-viral Vector Head office and Area Served    30

3.6 Global Key Players of Viral and Non-viral Vector, Product    31

3.7 Global Key Players of Viral and Non-viral Vector, Founded Date                 31

3.8 Mergers & Acquisitions, Expansion Plans 32

4 Viral and Non-viral Vector Breakdown Data by Type 34

4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2019-2024)      34

4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030)           35

5 Viral and Non-viral Vector Breakdown Data by Application     36

5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2019-2024)           36

5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030)     37

6 North America   38

6.1 North America Viral and Non-viral Vector Market Size (2019-2030)                 38

6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030       38

6.3 North America Viral and Non-viral Vector Market Size by Country (2019-2024)           39

6.4 North America Viral and Non-viral Vector Market Size by Country (2025-2030)           39

6.5 United States  40

6.6 Canada             41

6.7 Mexico             42

7 Europe 43

7.1 Europe Viral and Non-viral Vector Market Size (2019-2030)                 43

7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030        43

7.3 Europe Viral and Non-viral Vector Market Size by Country (2019-2024)      44

7.4 Europe Viral and Non-viral Vector Market Size by Country (2025-2030)      44

7.5 Germany          45

7.6 France              46

7.7 U.K. 46

7.8 Italy  47

7.9 Russia               47

7.10 Spain              48

8 Asia-Pacific        49

8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2019-2030)                 49

8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030       49

8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024)      50

8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030)      50

8.5 China                52

8.6 Japan                52

8.7 South Korea    53

8.8 Southeast Asia                53

8.9 India 54

8.10 Australia        54

9 South America   55

9.1 South America Viral and Non-viral Vector Market Size (2019-2030)                 55

9.2 South America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030       55

9.3 South America Viral and Non-viral Vector Market Size by Country (2019-2024)           56

9.4 South America Viral and Non-viral Vector Market Size by Country (2025-2030)           56

9.5 Brazil                57

10 Middle East & Africa      58

10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2019-2030)      58

10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030  58

10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024)           59

10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030)           59

10.5 Middle East  60

10.6 Africa             61

11 Key Players Profiles        62

11.1 Thermo Fisher Scientific            62

11.1.1 Thermo Fisher Scientific Company Details         62

11.1.2 Thermo Fisher Scientific Business Overview       62

11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction                 63

11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024)          64

11.1.5 Thermo Fisher Scientific Recent Development   64

11.2 Lonza             65

11.2.1 Lonza Company Details          65

11.2.2 Lonza Business Overview        66

11.2.3 Lonza Viral and Non-viral Vector Introduction  66

11.2.4 Lonza Revenue in Viral and Non-viral Vector Business (2019-2024)                 68

11.2.5 Lonza Recent Development    68

11.3 Azenta Life Sciences   69

11.3.1 Azenta Life Sciences Company Details 69

11.3.2 Azenta Life Sciences Business Overview              70

11.3.3 Azenta Life Sciences Viral and Non-viral Vector Introduction                 70

11.3.4 Azenta Life Sciences Revenue in Viral and Non-viral Vector Business (2019-2024)          71

11.3.5 Azenta Life Sciences Recent Development          72

11.4 Revvity           73

11.4.1 Revvity Company Details        73

11.4.2 Revvity Business Overview     73

11.4.3 Revvity Viral and Non-viral Vector Introduction                 74

11.4.4 Revvity Revenue in Viral and Non-viral Vector Business (2019-2024)      76

11.5 VectorBuilder               76

11.5.1 VectorBuilder Company Details            76

11.5.2 VectorBuilder Business Overview          77

11.5.3 VectorBuilder Viral and Non-viral Vector Introduction    77

11.5.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024)           79

11.5.5 VectorBuilder Recent Development      80

11.6 Takara Bio    81

11.6.1 Takara Bio Company Details 81

11.6.2 Takara Bio Business Overview               81

11.6.3 Takara Bio Viral and Non-viral Vector Introduction          82

11.6.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024)      86

11.6.5 Takara Bio Recent Development           86

11.7 GenScript Biotech       88

11.7.1 GenScript Biotech Company Details    88

11.7.2 GenScript Biotech Business Overview  89

11.7.3 GenScript Biotech Viral and Non-viral Vector Introduction                 89

11.7.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024)           90

11.7.5 GenScript Biotech Recent Development              91

11.8 Gene Chem  92

11.8.1 Gene Chem Company Details                92

11.8.2 Gene Chem Business Overview              92

11.8.3 Gene Chem Viral and Non-viral Vector Introduction        93

11.8.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024)      94

11.9 Geno Meditech             94

11.9.1 Geno Meditech Company Details          95

11.9.2 Geno Meditech Business Overview       95

11.9.3 Geno Meditech Viral and Non-viral Vector Introduction  96

11.9.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024)           97

11.10 PackGene Biotech     98

11.10.1 PackGene Biotech Company Details  98

11.10.2 PackGene Biotech Business Overview                99

11.10.3 PackGene Biotech Viral and Non-viral Vector Introduction                 99

11.10.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024)          100

11.11 VIROVEK  101

11.11.1 VIROVEK Company Details                101

11.11.2 VIROVEK Business Overview              102

11.11.3 VIROVEK Viral and Non-viral Vector Introduction         102

11.11.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024)      103

11.11.5 VIROVEK Recent Development          104

11.12 OriGen        104

11.12.1 OriGen Company Details     104

11.12.2 OriGen Business Overview  105

11.12.3 OriGen Viral and Non-viral Vector Introduction              105

11.12.4 OriGen Revenue in Viral and Non-viral Vector Business (2019-2024)      106

11.13 Vector BioLabs          107

11.13.1 Vector BioLabs Company Details        107

11.13.2 Vector BioLabs Business Overview     108

11.13.3 Vector BioLabs Viral and Non-viral Vector Introduction                 108

11.13.4 Vector BioLabs Revenue in Viral and Non-viral Vector Business (2019-2024)           109

11.13.5 Vector BioLabs Recent Development 110

12 Analyst’s Viewpoints/Conclusions                111

13 Appendix          113

13.1 Research Methodology                113

13.1.1 Methodology/Research Approach         113

13.1.2 Data Source               116

13.2 Author Details              119

13.3 Disclaimer    119

Tables and Figures

Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030   1

Table 2. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030        7

Table 3. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2019 VS 2023 VS 2030             16

Table 4. Global Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million)        18

Table 5. Global Viral and Non-viral Vector Market Share by Region (2019-2024)      18

Table 6. Global Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030) & (US$ Million)               19

Table 7. Global Viral and Non-viral Vector Market Share by Region (2025-2030)      19

Table 8. Viral and Non-viral Vector Market Trends       19

Table 9. Viral and Non-viral Vector Market Drivers      21

Table 10. Viral and Non-viral Vector Market Challenges              22

Table 11. Viral and Non-viral Vector Market Restraints                23

Table 12. Global Viral and Non-viral Vector Revenue by Players (2019-2024) & (US$ Million)        24

Table 13. Global Viral and Non-viral Vector Market Share by Players (2019-2024)           25

Table 14. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2023)               26

Table 15. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2023    27

Table 16. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI) & (2019-2024)             29

Table 17. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served   30

Table 18. Global Key Players of Viral and Non-viral Vector, Product                 31

Table 19. Global Key Players of Viral and Non-viral Vector, Founded Date                 31

Table 20. Mergers & Acquisitions, Expansion Plans      32

Table 21. Global Viral and Non-viral Vector Market Size by Type (2019-2024) & (US$ Million)        34

Table 22. Global Viral and Non-viral Vector Revenue Market Share by Type (2019-2024)                 34

Table 23. Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030) & (US$ Million)  35

Table 24. Global Viral and Non-viral Vector Revenue Market Share by Type (2025-2030)                 35

Table 25. Global Viral and Non-viral Vector Market Size by Application (2019-2024) & (US$ Million)            36

Table 26. Global Viral and Non-viral Vector Revenue Market Share by Application (2019-2024)     36

Table 27. Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030) & (US$ Million)       37

Table 28. Global Viral and Non-viral Vector Revenue Market Share by Application (2025-2030)     37

Table 29. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030                38

Table 30. North America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)             39

Table 31. North America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)             39

Table 32. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030              43

Table 33. Europe Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)            44

Table 34. Europe Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)            44

Table 35. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030                49

Table 36. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million)            50

Table 37. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030) & (US$ Million)            50

Table 38. South America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030                55

Table 39. South America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)             56

Table 40. South America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)             56

Table 41. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 58

Table 42. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)             59

Table 43. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)             59

Table 44. Thermo Fisher Scientific Company Details   62

Table 45. Thermo Fisher Scientific Business Overview 62

Table 46. Thermo Fisher Scientific Viral and Non-viral Vector Product                 63

Table 47. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            64

Table 48. Thermo Fisher Scientific Recent Development             64

Table 49. Lonza Company Details    65

Table 50. Lonza Business Overview  66

Table 51. Lonza Viral and Non-viral Vector Product     66

Table 52. Lonza Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)        68

Table 53. Lonza Recent Development              68

Table 54. Azenta Life Sciences Company Details           69

Table 55. Azenta Life Sciences Business Overview        70

Table 56. Azenta Life Sciences Viral and Non-viral Vector Product                 70

Table 57. Azenta Life Sciences Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            71

Table 58. Azenta Life Sciences Recent Development    72

Table 59. Revvity Company Details  73

Table 60. Revvity Business Overview                73

Table 61. Revvity Viral and Non-viral Vector Product  74

Table 62. Revvity Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)        76

Table 63. VectorBuilder Company Details      76

Table 64. VectorBuilder Business Overview    77

Table 65. VectorBuilder Viral and Non-viral Vector Product       77

Table 66. VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            79

Table 67. VectorBuilder Recent Development                80

Table 68. Takara Bio Company Details            81

Table 69. Takara Bio Business Overview         81

Table 70. Takara Bio Viral and Non-viral Vector Product             82

Table 71. Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            86

Table 72. Takara Bio Recent Development     86

Table 73. GenScript Biotech Company Details               88

Table 74. GenScript Biotech Business Overview            89

Table 75. GenScript Biotech Viral and Non-viral Vector Product                 89

Table 76. GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            90

Table 77. GenScript Biotech Recent Development        91

Table 78. Gene Chem Company Details          92

Table 79. Gene Chem Business Overview        92

Table 80. Gene Chem Viral and Non-viral Vector Product           93

Table 81. Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            94

Table 82. Geno Meditech Company Details    95

Table 83. Geno Meditech Business Overview 95

Table 84. Geno Meditech Viral and Non-viral Vector Product    96

Table 85. Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            97

Table 86. PackGene Biotech Company Details               98

Table 87. PackGene Biotech Business Overview            99

Table 88. PackGene Biotech Viral and Non-viral Vector Product                 99

Table 89. PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            100

Table 90. VIROVEK Company Details             101

Table 91. VIROVEK Business Overview          102

Table 92. VIROVEK Viral and Non-viral Vector Product             102

Table 93. VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            103

Table 94. VIROVEK Recent Development      104

Table 95. OriGen Company Details 104

Table 96. OriGen Business Overview               105

Table 97. OriGen Viral and Non-viral Vector Product  105

Table 98. OriGen Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)        106

Table 99. Vector BioLabs Company Details    107

Table 100. Vector BioLabs Business Overview                108

Table 101. Vector BioLabs Viral and Non-viral Vector Product  108

Table 102. Vector BioLabs Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)            109

Table 103. Vector BioLabs Recent Development            110

Table 104. Research Programs/Design for This Report                 113

Table 105. Key Data Information from Secondary Sources           117

Table 106. Key Data Information from Primary Sources               118

Table 107. Authors List of This Report             119

List of Figures

Figure 1. Global Viral and Non-viral Vector Market Size Comparison by Type (2024-2030) & (US$ Million)  2

Figure 2. Global Viral and Non-viral Vector Market Share by Type: 2023                 3

Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2030                 3

Figure 4. AAV Features       4

Figure 5. Global Viral and Non-viral Vector Market Size by Application (2024-2030) & (US$ Million)            8

Figure 6. Global Viral and Non-viral Vector Market Share by Application: 2023        9

Figure 7. Global Viral and Non-viral Vector Market Share by Application: 2030        9

Figure 8. Pharmaceutical and Biopharmaceutical Companies Case Studies                 10

Figure 9. Academics and Research Institutes Case Studies           11

Figure 10. Viral and Non-viral Vector Report Years Considered 13

Figure 11. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2019-2030                 14

Figure 12. Global Viral and Non-viral Vector Market Size, (US$ Million), 2019 VS 2024 VS 2030        15

Figure 13. Global Viral and Non-viral Vector Market Share by Region: 2023        17

Figure 14. Global Viral and Non-viral Vector Market Share by Region: 2030        18

Figure 15. Global Viral and Non-viral Vector Market Share by Players in 2023        26

Figure 16. The Top 5 Players Market Share by Viral and Non-viral Vector Revenue in 2023   29

Figure 17. The Top 10 Players Market Share by Viral and Non-viral Vector Revenue in 2023   30

Figure 18. North America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              38

Figure 19. North America Viral and Non-viral Vector Market Share by Country (2019-2030)           40

Figure 20. United States Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              40

Figure 21. Canada Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            41

Figure 22. Mexico Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            42

Figure 23. Europe Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            43

Figure 24. Europe Viral and Non-viral Vector Market Share by Country (2019-2030)           45

Figure 25. Germany Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            45

Figure 26. France Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            46

Figure 27. U.K. Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            46

Figure 28. Italy Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            47

Figure 29. Russia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            47

Figure 30. Spain Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            48

Figure 31. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              49

Figure 32. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2019-2030)           51

Figure 33. China Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            52

Figure 34. Japan Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            52

Figure 35. South Korea Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              53

Figure 36. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              53

Figure 37. India Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            54

Figure 38. Australia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            54

Figure 39. South America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              55

Figure 40. South America Viral and Non-viral Vector Market Share by Country (2019-2030)           57

Figure 41. Brazil Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            57

Figure 42. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)     58

Figure 43. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2019-2030)      60

Figure 44. Middle East Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)              60

Figure 45. Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)            61

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)            64

Figure 47. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)          68

Figure 48. Azenta Life Sciences Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)     72

Figure 49. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)          76

Figure 50. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)              80

Figure 51. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)          86

Figure 52. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)              91

Figure 53. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)              94

Figure 54. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)              98

Figure 55. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)              101

Figure 56. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)          103

Figure 57. OriGen Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)          107

Figure 58. Vector BioLabs Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)              110

Figure 59. Bottom-up and Top-down Approaches for This Report                 115

Figure 60. Data Triangulation            116

Figure 61. Key Executives Interviewed              118

QYResearchは広範な市場を対象にし、多様な市場調査レポートを出版している中国北京に本社をおく市場調査会社です。QYResearch出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。

QYResearch 出版レポート一覧

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイル閲覧可のライセンスです。
    • 提供ファイルはPDFファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • マルチユーザライセンス
    • 同一企業内10名までレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • エンタープライズライセンス
    • 同一企業および関連会社内において人数無制限でレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
• 納期
  • 既刊レポート：ご注文後3営業日以内
  • オンデマンドレポート：通常7営業日前後

• 納品形態
  • Eメール

注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。